Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccination Grant US-9650614-B2 United States of America 16 May 2017
Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccination Grant US-8980287-B2 United States of America 17 Mar 2015